Speciality Medicines IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
SME IPO
SPECIALITYMEDICINES
Speciality Medicines IPO GMP, Subscription & Allotment Status Today
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
- Price Band
- ₹117.00 - ₹124.00
- Lot Size
- 1,000 Shares
- Bidding Closes
- 24 Mar 2026
- Listing Date
- 30 Mar 2026
Current GMP Status
₹0
+0% vs upper band
Est. Listing Gain
+0.00%
Last Trend
26 Mar 2026
Listing Price
₹124.00
Retail Entry
₹2,48,000
IPO Details
Complete IPO information
| Current GMP | ₹0 |
|---|---|
| Estimated Listing Gain | +0.00% |
| Price Band | ₹117.00 - ₹124.00 |
| Issue Price | Approx ₹124.00 Crores |
| Listing Price | ₹124.00 |
| Lot Size | 1,000 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | 2.27x |
| Listing Date | 30 Mar 2026 |
| Minimum Investment | ₹2,48,000 |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Speciality Medicines is priced at ₹124 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,48,000 to participate in this SME issue.
The latest recorded Grey Market Premium for Speciality Medicines stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Speciality Medicines's IPO was subscribed 2.27x overall, with a category-wise breakdown of Retail 0.85x, QIB 96.24x.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
20 Mar 2026
✓
Bidding Closes
24 Mar 2026
✓
Allotment
TBA
✓
Listing
30 Mar 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 26 Mar 2026 | ₹0.00 | - | 0.00% |
| 24 Mar 2026 | ₹0.00 | - | 0.00% |
| 23 Mar 2026 | ₹0.00 | - | 0.00% |
| 18 Mar 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,48,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,48,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹3,72,000 |
| S-HNI Maximum | 8 Lot | 8,000 | ₹9,92,000 |
| B-HNI Minimum | 9 Lot | 9,000 | ₹11,16,000 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
IPO Details
| IPO Open Date | March 20, 2026 |
|---|---|
| IPO Close Date | March 24, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹117 to ₹124 Per Share |
| Issue Size | Approx ₹29.14 Crores |
| Fresh Issue | Approx ₹29.14 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
Analysis
IPO Reservation
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 2% |
| NII Shares Offered | — Shares | 49% |
| Retail Shares Offered | — Shares | 49% |
Analysis
Speciality Medicines IPO Anchor Investors
| Anchor Bidding Date | 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Analysis
Speciality Medicines IPO Dates
| IPO Open Date | March 20, 2026 |
|---|---|
| IPO Close Date | March 24, 2026 |
| Basis of Allotment | March 25, 2026 |
| Refunds | March 27, 2026 |
| Credit to Demat Account | March 27, 2026 |
| IPO Listing Date | March 30, 2026 |
| Bidding Cut-off Time | March 24, 2026 – 5 PM |
Analysis
Promoters and Holding Pattern
| Promoters | Parth B Goyani and Goyani Sumit Babubhai |
|---|---|
| Promoter Holding Pre Issue | 64,35,796 Shares (59.28%) |
| Promoter Holding Post Issue | 87,85,796 Shares (43.44%) |
Analysis
Objects of the Issue & Utilisation of Proceeds
| Setting up of the Research and Development (R&D) Centre | ₹13.31 Cr. |
|---|---|
| Product registration in the international markets | ₹2.89 Cr. |
| Repayment / Prepayment of Borrowings | ₹1.75 Cr. |
| Working Capital Requirements | ₹12.00 Cr. |
| General Corporate Purpose | ₹— |
Analysis
Speciality Medicines IPO Company Financial Report
| Period Ended | Revenue (₹ Cr.) | Expense (₹ Cr.) | PAT (₹ Cr.) | Assets (₹ Cr.) |
|---|---|---|---|---|
| 2024 | 27.66 | 23.10 | 2.93 | 22.68 |
| 2025 | 58.54 | 49.85 | 8.61 | 39.98 |
| Oct 2025 | 36.93 | 30.80 | 6.06 | 45.57 |
Analysis
Speciality Medicines IPO Valuation – FY2025
| KPI | Values |
|---|---|
| ROE | 37.85% |
| ROCE | 33.39% |
| EBITDA Margin | 15.60% |
| PAT Margin | 14.77% |
| Debt to Equity Ratio | 0.17 |
| EPS (Basic) | ₹14.10 |
| P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 28.42% |
| Net Asset Value (NAV) | ₹47.07 |
Analysis
Peer Group Comparison
| Company | EPS | P/E Ratio | RoNW % | NAV | Income (₹ Cr.) |
|---|---|---|---|---|---|
| Remus Pharmaceuticals Limited | 65.21 | 12.25 | 15.02% | 434.25 | 620.36 |
| Trident Lifeline Limited | 10.22 | 27.59 | 18.23% | 56.05 | 86.96 |
| Mono Pharmacare Limited | 1.75 | 13.87 | 9.90% | 17.66 | 168.34 |
Analysis
IPO Lead Managers aka Merchant Bankers
- Unicon Capital Services Pvt. Ltd.
FAQ
Speciality Medicines IPO FAQs
Speciality Medicines IPO price band is Rs 117.00 to Rs 124.00. Check the latest issue price, lot size and GMP together before applying.
Speciality Medicines IPO open date is 20 Mar 2026, close date is 24 Mar 2026, and listing date is 30 Mar 2026.
Speciality Medicines IPO lot size is 1,000 shares. The minimum retail investment is Rs 2,48,000.
Speciality Medicines is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Speciality Medicines IPO subscription status currently shows Retail 0.85x, QIB 96.24x, Overall 2.27x.
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
Community discussion
Comments
Share a useful question or insight about Speciality Medicines.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
SME
Himalayan Solar
Price Band₹98.00 - ₹103.00
Current GMP₹0
Lot Size1,200 Shares
SME
Bench Mark Infotech Services
Price Band₹104.00 - ₹110.00
Current GMP₹12 · +10.9%
Lot Size1,200 Shares
SME
Liqvd Digital
Price Band₹51.00 - ₹54.00
Current GMP₹0
Lot Size2,000 Shares
SME
Pooja Logistics
Price Band₹109.00 - ₹115.00
Current GMPN/A
Lot Size1,200 Shares
Loading comments...